K. Ikeda

发表

Intraarterial delivery of adenovirus vectors and liposome-DNA complexes to experimental brain neoplasms.

E. Chiocca, N. Rainov, X. Breakefield, 1999, Human gene therapy.

Selective delivery of herpes virus vectors to experimental brain tumors using RMP-7

X. Breakefield, N. Rainov, G. Harsh, 1999, Cancer Gene Therapy.

Intra-arterial virus and nonvirus vector-mediated gene transfer to experimental rat brain tumors.

A. Quiñones, E. Chiocca, N. Rainov, 1999, Frontiers of radiation therapy and oncology.

Regression of experimental brain tumors with 6-thioxanthine and Escherichia coli gpt gene therapy.

T. Tamiya, G. Harsh, E. Chiocca, 1997, Human gene therapy.

Complement Depletion Facilitates the Infection of Multiple Brain Tumors by an Intravascular, Replication-Conditional Herpes Simplex Virus Mutant

H. Wakimoto, E. Chiocca, F. Hochberg, 2000, Journal of virology.

The complement response against an oncolytic virus is species-specific in its activation pathways.

H. Wakimoto, T. Abe, E. Chiocca, 2002, Molecular therapy : the journal of the American Society of Gene Therapy.

Pre-existing herpes simplex virus 1 (HSV-1) immunity decreases, but does not abolish, gene transfer to experimental brain tumors by a HSV-1 vector

D. Finkelstein, D. Louis, E. Chiocca, 1998, Gene Therapy.

Inhibition of NF2-negative and NF2-positive primary human meningioma cell proliferation by overexpression of merlin due to vector-mediated gene transfer.

E. Chiocca, C. Gonzalez-agosti, V. Ramesh, 1999, Journal of neurosurgery.

Oncolytic virus therapy of multiple tumors in the brain requires suppression of innate and elicited antiviral responses

D. Louis, H. Wakimoto, T. Deisboeck, 1999, Nature Medicine.

Functional response of tumor vasculature to PaCO2: determination of total and microvascular blood volume by MRI.

E. A. Chiocca, B. Rosen, J. Mandeville, 2003, Neoplasia.